Pharmacological Control of Receptor of Advanced Glycation End-Products and its Biological Effects in Psoriasis

@inproceedings{Mezentsev2013PharmacologicalCO,
  title={Pharmacological Control of Receptor of Advanced Glycation End-Products and its Biological Effects in Psoriasis},
  author={Alexander V. Mezentsev and Sergey A Bruskin and Anna G. Soboleva and Valeriy Sobolev and E. S. Piruzian},
  booktitle={International journal of biomedical science : IJBS},
  year={2013}
}
Receptor for advanced glycation end-products is implicated in a development of chronic inflammatory response. Aim of this paper is to provide a review on commercial and experimental medicines that can interfere with RAGE and signaling through RAGE. We searched three bibliographical databases (PubMed, Web of Science and MEDLINE) for the publications from 2005 to March 2012 and identified 5 major groups of agents that can interfere with RAGE biological effects. In the first part of this paper, we… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 139 REFERENCES

Alagebrium chloride protects the heart against oxidative stress in aging rats.

  • The journals of gerontology. Series A, Biological sciences and medical sciences
  • 2009
VIEW 15 EXCERPTS
HIGHLY INFLUENTIAL

Peripheral Expression of Jak3 Is Required to Maintain T Lymphocyte Function

  • The Journal of experimental medicine
  • 1997
VIEW 8 EXCERPTS
HIGHLY INFLUENTIAL

Preliminary clinical activity of a topical JAK1/2 inhibitor in the treatment of psoriasis.

  • Journal of the American Academy of Dermatology
  • 2012
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs.

  • American journal of physiology. Endocrinology and metabolism
  • 2008
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…